Deciphex Raises $11.5M in Series B Funding Led by ACT Venture Capital
Deciphex will leverage the funding to continue driving global growth and to consolidate its position as a leader in revolutionising clinical and non-clinical pathology
Deciphex will leverage the funding to continue driving global growth and to consolidate its position as a leader in revolutionising clinical and non-clinical pathology